Single and Multiple Ascending Dose Study of TD-8236 by Inhalation

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions

Asthma

Interventions

DRUG

TD-8236

Study drug to be administered via inhaler device

DRUG

Placebo

Placebo to be administered via inhaler device

Trial Locations (2)

Theravance Biopharma Investigational Site, Manchester

Theravance Biopharma Investigational Site, Belfast